Involvement of the central nervous system in the salivary secretion induced by pilocarpine in rats.
The effect of rats of an anteroventral third ventricle (AV3V) electrolytic lesion on salivary secretion induced by intraperitoneal (i.p.) or intracerebroventricular (i.c.v.) injection of a cholinergic agonist (pilocarpine) was investigated. Sham- or AV3V-lesioned rats anesthetized with urethane and with a stainless steel cannula implanted into the lateral ventricle (LV) were used. The amount of salivary secretion was studied over a seven-minute period after i.c.v. or i.p. injection of pilocarpine. In sham-operated rats, i.p. injection of pilocarpine (1 mg/kg b.w.) (after 6 h, 2, 7, and 15 days) produced salivary secretion (486 +/- 21, 778 +/- 85, 630 +/- 50, and 560 +/- 55 mg/7 min, respectively). This effect was reduced 6 h, 2, and 7 days after an AV3V lesion (142 +/- 22, 113 +/- 32, and 290 +/- 62 mg/7 min, respectively), but not 15 days after an AV3V lesion (516 +/- 19 mg/7 min). I.c.v. injection of pilocarpine (120 micrograms in 1 microL), in sham-operated rats after 6 h, 2, 7, and 15 days also produced salivary secretion (443 +/- 20, 417 +/- 81, 496 +/- 14, and 427 +/- 47 mg/7 min, respectively). The effects of i.c.v. pilocarpine were also reduced 6 h, 2, and 7 days after an AV3V lesion (143 +/- 19, 273 +/- 14, and 322 +/- 17 mg/7 min, respectively), but not after 15 days (450 +/- 28 mg/7 min). The results demonstrate that the central nervous system, and particularly the AV3V region, is important for the effect of pilocarpine on salivary secretion in rats.(ABSTRACT TRUNCATED AT 250 WORDS)
Renzi
A
A
Department of Physiology, School of Dentistry, Paulista State University, SP, Brazil.
Colombari
E
E
Mattos Filho
T R
TR
Silveira
J E
JE
Saad
W A
WA
Camargo
L A
LA
de Luca Júnior
L A
LA
Deróbio
J G
JG
Menani
J V
JV
D000818:Animals; D001927:Brain Diseases / Q000473:pathology / Q000503:physiopathology; D002552:Cerebral Ventricles / Q000187:drug effects / Q000473:pathology / Q000502:physiology*; D007267:Injections; D007274:Injections, Intraperitoneal; D008297:Male; D009434:Neural Pathways / Q000187:drug effects / Q000502:physiology; D010862:Pilocarpine / Q000008:administration & dosage / Q000494:pharmacology*; D016548:Prosencephalon / Q000187:drug effects / Q000473:pathology / Q000502:physiology*; D051381:Rats; D012463:Saliva / Q000187:drug effects* / Q000378:metabolism*; D012469:Salivary Glands / Q000187:drug effects / Q000294:innervation* / Q000378:metabolism; D012636:Secretory Rate / Q000187:drug effects; D013997:Time Factors
D010862:Pilocarpine